In addition, we observed an increase in the proportion of CD8+T cells in splenocytes, which indicated the long‐term immune effect of FSP‐RZ‐BPH treatment and its potential as a preventive vaccine (Figure 5n,o). This evidence concerns the gene CD8A and benign prostatic hyperplasia.